CVS Health Co. (NYSE:CVS) Shares Sold by TCW Group Inc.

TCW Group Inc. trimmed its position in shares of CVS Health Co. (NYSE:CVS) by 2.3% during the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 17,166 shares of the pharmacy operator’s stock after selling 405 shares during the quarter. TCW Group Inc.’s holdings in CVS Health were worth $1,079,000 at the end of the most recent quarter.

A number of other hedge funds have also recently added to or reduced their stakes in CVS. Soltis Investment Advisors LLC boosted its stake in shares of CVS Health by 1.3% in the third quarter. Soltis Investment Advisors LLC now owns 100,789 shares of the pharmacy operator’s stock valued at $6,338,000 after buying an additional 1,342 shares in the last quarter. TD Private Client Wealth LLC lifted its holdings in CVS Health by 28.7% in the third quarter. TD Private Client Wealth LLC now owns 46,938 shares of the pharmacy operator’s stock valued at $2,951,000 after acquiring an additional 10,465 shares during the period. Toronto Dominion Bank boosted its position in shares of CVS Health by 124.6% during the 3rd quarter. Toronto Dominion Bank now owns 1,508,071 shares of the pharmacy operator’s stock worth $94,828,000 after purchasing an additional 836,569 shares in the last quarter. Coldstream Capital Management Inc. increased its holdings in shares of CVS Health by 27.8% in the 3rd quarter. Coldstream Capital Management Inc. now owns 17,400 shares of the pharmacy operator’s stock valued at $1,084,000 after purchasing an additional 3,788 shares in the last quarter. Finally, Geode Capital Management LLC lifted its stake in shares of CVS Health by 1.8% in the third quarter. Geode Capital Management LLC now owns 26,361,673 shares of the pharmacy operator’s stock valued at $1,651,997,000 after purchasing an additional 461,569 shares during the period. Institutional investors and hedge funds own 80.66% of the company’s stock.

Analysts Set New Price Targets

A number of research analysts have issued reports on the stock. Cantor Fitzgerald reaffirmed a “neutral” rating and issued a $62.00 target price on shares of CVS Health in a report on Tuesday, October 1st. Evercore ISI raised their price objective on CVS Health from $62.00 to $75.00 and gave the company an “outperform” rating in a research note on Tuesday, October 8th. UBS Group boosted their target price on CVS Health from $60.00 to $62.00 and gave the stock a “neutral” rating in a research report on Thursday, November 7th. StockNews.com cut CVS Health from a “hold” rating to a “sell” rating in a research report on Thursday, November 14th. Finally, Royal Bank of Canada lowered their price objective on shares of CVS Health from $68.00 to $58.00 and set an “outperform” rating on the stock in a research note on Friday, November 15th. One analyst has rated the stock with a sell rating, six have issued a hold rating and fourteen have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus target price of $70.50.

CVS Health Trading Down 4.2 %

Shares of CVS Health stock opened at $49.59 on Friday. The firm has a market cap of $62.40 billion, a PE ratio of 12.59, a P/E/G ratio of 0.89 and a beta of 0.54. The company has a quick ratio of 0.59, a current ratio of 0.80 and a debt-to-equity ratio of 0.80. CVS Health Co. has a fifty-two week low of $49.47 and a fifty-two week high of $83.25. The business’s fifty day moving average is $58.86 and its two-hundred day moving average is $58.75.

CVS Health (NYSE:CVS) last issued its quarterly earnings results on Wednesday, November 6th. The pharmacy operator reported $1.09 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.08 by $0.01. CVS Health had a return on equity of 10.72% and a net margin of 1.36%. The firm had revenue of $95.43 billion for the quarter, compared to analyst estimates of $92.72 billion. During the same period last year, the company earned $2.21 EPS. The firm’s quarterly revenue was up 6.3% on a year-over-year basis. Analysts anticipate that CVS Health Co. will post 5.32 earnings per share for the current year.

CVS Health Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Friday, November 1st. Shareholders of record on Monday, October 21st were paid a dividend of $0.665 per share. This represents a $2.66 dividend on an annualized basis and a yield of 5.36%. The ex-dividend date of this dividend was Monday, October 21st. CVS Health’s dividend payout ratio is currently 67.51%.

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.